Ray Blanchard
Research psychiatrist and sexologist
Ray Blanchard coined the term autogynephilia in 1989 after fifteen years at a gender identity clinic, producing a typology of male-to-female transsexualism that shaped clinical practice globally — and was then systematically marginalised. As Sweden, Finland and the Netherlands reckon with their own clinic cultures, his research has never felt more urgent for European audiences.
Ray Blanchard is a research psychiatrist and sexologist who spent the core of his career at the Clarke Institute of Psychiatry — later the Centre for Addiction and Mental Health (CAMH) — in Toronto, where he headed the Clinical Sexology Services. After fifteen years working directly with gender-dysphoric patients, he coined the term autogynephilia in 1989 to describe male-to-female transition driven not by a homosexual orientation toward men, but by a man's erotic attachment to the image of himself as a woman.
His two-type typology — distinguishing homosexual from autogynephilic transsexualism — drew on systematic clinical data and became one of the most cited frameworks in sexology. It also became one of the most politically targeted. When J. Michael Bailey popularised the theory in his 2003 book "The Man Who Would Be Queen," a coordinated campaign sought to discredit both men. Scholar Alice Dreger later documented that Blanchard's work was not refuted scientifically but subjected to organised suppression. Blanchard also served on the DSM-5 Sexual and Gender Identity Disorders Work Group, shaping the diagnostic categories that gender clinics worldwide relied upon — making the subsequent erasure of his framework from clinical guidance all the more consequential.
In the Beyond Gender episode "Autogynephilia: The Study Activists Wanted Buried" (episode 41, October 2025), hosts Stella O'Malley, Mia Hughes and Dr Bret Alderman examine with Blanchard why his typology was suppressed and what that suppression cost. For European listeners, the question lands with particular force. Sweden's Karolinska, Finland's gender clinics and the Dutch teams that pioneered the paediatric protocol have all begun formal scrutiny of their own practice. Blanchard's research — sidelined precisely when clinics across the continent were expanding fastest — is essential background for every European clinician, regulator and patient now reckoning with what went wrong.
